+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Laryngeal Cancer Therapeutics Market 2019-2023 - Product Image

Global Laryngeal Cancer Therapeutics Market 2019-2023

  • ID: 4769627
  • Report
  • Region: Global
  • 121 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Bristol-Myers Squibb Co.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co. Inc.
  • Sanofi
  • MORE
About this market

The increasing number of reimbursement programs is one of the key factors expected to boost the laryngeal cancer therapeutics market growth in the forthcoming years. Various governments and vendors are launching patient assistance programs for reducing the high-cost burden associated with the treatment using therapeutics and providing the treatment at an affordable price. As a result, increasing number of patient assistance programs will lead the laryngeal cancer therapeutics market growth during the forecast period. The analysts have predicted that the laryngeal cancer therapeutics market will register a CAGR of over 7% by 2023.

Market Overview

A growing number of strategic alliances

The increasing number of strategic alliances among vendors is expected to result in the launch of more advanced therapies and quicker approval. The laryngeal cancer therapeutics market has witnessed strategic alliance for the development of commercialization of drugs for the treatment of laryngeal cancer. This will drive the growth of the market during the forecast period.

Clinical trial failures

The heavy cost involved in recruiting patients for trials and the high cost of the drug cause a significant loss to vendors when a clinical trial fail. Hence, these clinical trial failures are expected to pose a threat to the market growth during the forecast period.

For the detailed list of factors that will drive and challenge the growth of the laryngeal cancer therapeutics market during 2019-2023, view the full report.

Competitive Landscape

The market appears to be concentrated with the presence of a few market players. Several organizations are focusing on raising awareness about the head and neck cancer also provides funding for drugs and therapeutics for the treatment and cure of laryngeal cancer. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bristol-Myers Squibb Co.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co. Inc.
  • Sanofi
  • MORE

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • Preface
  • Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: PIPELINE

PART 07: MARKET SEGMENTATION BY TYPE

  • Market segmentation by type
  • Comparison by type
  • Biologics - Market size and forecast 2018-2023
  • Small molecules - Market size and forecast 2018-2023
  • Market opportunity by type

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bristol-Myers Squibb Co.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co. Inc.
  • Sanofi

PART 15: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of vendors classification

List of Exhibits
Exhibit 01: Global oncology therapeutics market
Exhibit 02: Segments of global oncology therapeutics market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Global laryngeal cancer therapeutics market pipeline: Overview
Exhibit 18: Global laryngeal cancer therapeutics market pipeline: Snapshot
Exhibit 19: Type - Market share 2018-2023 (%)
Exhibit 20: Comparison by type
Exhibit 21: Biologics - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Biologics - Year-over-year growth 2019-2023 (%)
Exhibit 23: Small molecules - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Popular chemotherapies for treatment of laryngeal cancer
Exhibit 25: Small molecules - Year-over-year growth 2019-2023 (%)
Exhibit 26: Market opportunity by type
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2018-2023 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: North America - Year-over-year growth 2019-2023 (%)
Exhibit 32: Top 3 countries in North America
Exhibit 33: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 35: Top 3 countries in Europe
Exhibit 36: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 38: Top 3 countries in Asia
Exhibit 39: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 40: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 41: Top 3 countries in ROW
Exhibit 42: Key leading countries
Exhibit 43: Market opportunity
Exhibit 44: Impact of drivers and challenges
Exhibit 45: Vendor landscape
Exhibit 46: Landscape disruption
Exhibit 47: Vendors covered
Exhibit 48: Vendor classification
Exhibit 49: Market positioning of vendors
Exhibit 50: Bristol-Myers Squibb Co. - Vendor overview
Exhibit 51: Bristol-Myers Squibb Co. - Product segments
Exhibit 52: Bristol-Myers Squibb Co. - Organizational developments
Exhibit 53: Bristol-Myers Squibb Co. - Geographic focus
Exhibit 54: Bristol-Myers Squibb Co. - Key offerings
Exhibit 55: Bristol-Myers Squibb Co. - Key customers
Exhibit 56: Eli Lilly and Co. - Vendor overview
Exhibit 57: Eli Lilly and Co. - Business segments
Exhibit 58: Eli Lilly and Co. - Organizational developments
Exhibit 59: Eli Lilly and Co. - Geographic focus
Exhibit 60: Eli Lilly and Co. - Segment focus
Exhibit 61: Eli Lilly and Co. - Key offerings
Exhibit 62: Eli Lilly and Co. - Key customers
Exhibit 63: F. Hoffmann-La Roche Ltd. - Vendor overview
Exhibit 64: F. Hoffmann-La Roche Ltd. - Business segments
Exhibit 65: F. Hoffmann-La Roche Ltd. - Organizational developments
Exhibit 66: F. Hoffmann-La Roche Ltd. - Geographic focus
Exhibit 67: F. Hoffmann-La Roche Ltd. - Segment focus
Exhibit 68: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibit 69: F. Hoffmann-La Roche Ltd. - Key customers
Exhibit 70: Merck & Co. Inc. - Vendor overview
Exhibit 71: Merck & Co. Inc. - Business segments
Exhibit 72: Merck & Co. Inc. - Organizational developments
Exhibit 73: Merck & Co. Inc. - Geographic focus
Exhibit 74: Merck & Co. Inc. - Segment focus
Exhibit 75: Merck & Co. Inc. - Key offerings
Exhibit 76: Merck & Co. Inc. - Key customers
Exhibit 77: Sanofi - Vendor overview
Exhibit 78: Sanofi - Business segments
Exhibit 79: Sanofi - Organizational developments
Exhibit 80: Sanofi - Geographic focus
Exhibit 81: Sanofi - Segment focus
Exhibit 82: Sanofi - Key offerings
Exhibit 83: Sanofi - Key customers
Exhibit 84: Validation techniques employed for market sizing
Exhibit 85: Definition of vendors classification

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Bristol-Myers Squibb Co.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co. Inc.
  • Sanofi
  • MORE
Global Laryngeal Cancer Therapeutics Market 2019-2023

The analyst recognizes the following companies as the key players in the global laryngeal cancer therapeutics market: Bristol-Myers Squibb Co., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., and Sanofi.

Commenting on the report, an analyst from the team said: “The latest trend gaining momentum in the market is the last stage pipeline.”

According to the report, one of the major drivers for this market is the growing number of strategic alliances.

Further, the report states that one of the major factors hindering the growth of this market is the clinical trial failures.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Bristol-Myers Squibb Co.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co. Inc.
  • Sanofi
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4769627
Adroll
adroll